Form DEFA14A NUCOR CORP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to § 240.14a-12 |
NUCOR CORPORATION
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required | |||
| ☐ | Fee paid previously with preliminary materials | |||
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |||
|
Your Vote Counts! |
||||||||||
|
NUCOR CORPORATION C/O PROXY SERVICES P.O. BOX 9142 FARMINGDALE, NY 11735 |
NUCOR CORPORATION
2024 Annual Meeting Vote by May 8, 2024 11:59 PM ET
|
|||||||||
|
| ||||||||||
|
| ||||||||||
|
| ||||||||||
| V36527-P06899-Z87059 | ||||||||||
You invested in NUCOR CORPORATION and its time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on May 9, 2024.
Get informed before you vote
View the Notice of Annual Meeting and Proxy Statement and the Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 25, 2024. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
* Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.
| Voting Items | Board Recommends | |||||||||
| 1. |
Election of the eight nominees as directors
Nominees:
|
|||||||||
| 01) Norma B. Clayton | 05) Laurette T. Koellner |
|
For | |||||||
| 02) Patrick J. Dempsey | 06) Michael W. Lamach | |||||||||
| 03) Nicholas C. Gangestad | 07) Leon J. Topalian | |||||||||
| 04) Christopher J. Kearney | 08) Nadja Y. West | |||||||||
| 2. |
Ratification of the appointment of PricewaterhouseCoopers LLP to serve as Nucors independent registered public accounting firm for 2024 |
|
For | |||||||
| 3. |
Approval, on an advisory basis, of Nucors named executive officer compensation in 2023 |
|
For
| |||||||
| In their discretion, the proxy holders are authorized to vote on such other business as may properly come before the meeting or any adjournment or postponement thereof. Each of proposals 1, 2 and 3 has been proposed by Nucor Corporation. |
||||||||||
|
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click Delivery Settings
|
V36528-P06899-Z87059
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NUE Power adds former Canadian minister Tony Clement to its board
- Nucor Invites You to Join Its Third Quarter of 2026 Conference Call on the Web
- MissionIRNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints CNS Drug Development Veteran Suresh Durgam to Board of DirectorsÂ
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share